Add BrightSurf on Google Email

IBEC-led consortium develops light-activated drugs that restore sight in blind mice

A new class of photoswitchable small molecule drugs has been developed to restore key visual functions in animal models of blindness. These compounds mimic the function of photoreceptor cells and show remarkable effectiveness at restoring sight using a simple and potentially patient-friendly approach.

SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalJournal of the American Chemical Society·TypeExperimental study·DateJul 15, 2026
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

A doorstop for the brain’s electrical gates

Scientists have captured detailed images of NMDA receptors held open by natural gatekeepers and synthetic regulators, revealing how they control ion flow. This understanding can inform the design of safe and effective therapies for conditions like Alzheimer's disease and stroke.

SourceCold Spring Harbor Laboratory·JournalNature·DateOct 29, 2025

CCM Biosciences scientists report discovery of first-in-class longevity therapeutics

Researchers at CCM Biosciences have discovered novel enzyme activators that fully restore the activity of Sirtuin-3, a master regulator of cellular energy production. These compounds hold significant potential for addressing age-related disorders such as Alzheimer's and Parkinson's diseases.

SourceCactus Communications·JournalPhysical Review X·TypeComputational simulation/modeling·DateJan 8, 2025

Experimental drug supercharges medicine that reverses opioid overdose

Researchers have identified a potential compound that enhances naloxone's effectiveness in reversing opioid overdoses by making it more potent and longer-lasting. The compound, dubbed compound 368, was found to improve naloxone's ability to counteract opioid overdoses in mice and enable reversal at lower doses.

SourceWashU Medicine·JournalNature·TypeExperimental study·DateJul 3, 2024

Obesity disrupts normal liver function in mice

Researchers found that obesity increases allosteric regulation during feeding and decreases it when fasting in mice livers. This disruption may lead to metabolic disorders like nonalcoholic fatty liver disease and Type 2 diabetes.

SourceUniversity of Tokyo·JournaliScience·TypeExperimental study·DateFeb 26, 2024

Researchers discover quantum switch for regulating photosynthesis

The study reveals a quantum switching mechanism of LHCII, which regulates energy transfer quantum channel in response to lateral pressure and conformational change. This mechanism enables high efficiency in photosynthesis and balanced photoprotection.

SourceChinese Academy of Sciences Headquarters·JournalNature Plants·TypeExperimental study·DateSep 1, 2023
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Ordered from afar: How germs’ toxins become dangerous

Scientists at the Max Planck Institute have uncovered how ExoY toxin becomes activated in human cells by binding to actin filaments, leading to devastating enzymatic activity. This discovery sheds light on a crucial molecular mechanism that underlies the pathogenicity of various toxins.

SourceMax Planck Institute of Molecular Physiology·JournalNature Communications·TypeExperimental study·DateNov 17, 2021

The landscape of protein tyrosine phosphatase (Shp2) and cancer

Recent studies have highlighted the significant role of Shp2, a phosphatase protein, in governing signaling response amplitude and regulating cell differentiation and growth. Dysregulation of Shp2 has been linked to various types of leukemia, including acute myeloid, juvenile myelomonocytic, and B-cell acute lymphoblastic leukemia.

SourceBentham Science Publishers·JournalCurrent Pharmaceutical Design·DateDec 27, 2018